| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |